Skip to main content
Explore URMC

URMC Logo

menu
URMC / Research / Research@URMC
Study Links Fitness Level and HIV-related Dementia

Study Links Fitness Level and HIV-related Dementia

More and more people with HIV are reaching their 50s and beyond thanks to advances in anti-retroviral therapies.  That is good news.  However, one of the long term impacts of living with the disease is a heightened risk of cognitive problems, such as dementia and functional decline.

Scientists Test Malaria Drug for Bone Diseases

Scientists Test Malaria Drug for Bone Diseases

Preclinical data suggest that a drug used to treat and prevent malaria and given previously as an anti-inflammatory could be repurposed to treat post-menopausal osteoporosis, according to a paper this week in the Journal of Clinical Investigation by Brendan F. Boyce, M.D., vice chair Anatomic Pathology at the URMC.

International Experts, Student Research Featured at World AIDS Day Symposium

International Experts, Student Research Featured at World AIDS Day Symposium

In honor of World AIDS Day, celebrated on December 1, 2013, the UR Center for AIDS Research (CFAR) hosted a scientific symposium featuring talks from prestigious experts in the AIDS community and research posters from undergraduate and graduate students and post doctoral associates training at UR. 

Hematology Event Draws Wilmot Scientists, New Data

Hematology Event Draws Wilmot Scientists, New Data

Several members of the lymphoma and leukemia teams at the James P. Wilmot Cancer Center are to present research at the 55th annual American Society of Hematology (ASH) meeting, Dec. 7 to 10, which is attended by more than 20,000 clinicians and scientists.

Batten Researchers Converge on Rochester

Batten Researchers Converge on Rochester

With incredibly rare diseases like Juvenile Batten Disease, the road map for moving research from the lab to patients is often unclear. This week, researchers, parents and representatives of advocacy groups from across the United States and Europe convene at the Medical Center to discuss the future of clinical trials for this devastating disorder.